These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34581321)

  • 1. Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy.
    Pradipta AR; Tanaka K
    Chem Commun (Camb); 2021 Sep; 57(77):9798-9806. PubMed ID: 34581321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unexplored Chemical Reactions of Endogenous Acrolein: Detection, Toxicity, and Biological Roles].
    Pradipta AR; Tanaka K
    Yakugaku Zasshi; 2017; 137(3):301-306. PubMed ID: 28250324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramethylrhodamine is an essential scaffold of azide probe in detecting cellular acrolein.
    Pradipta AR; Fujii M; Tanei T; Morimoto K; Shimazu K; Noguchi S; Tanaka K
    Bioorg Med Chem; 2019 Jun; 27(11):2228-2234. PubMed ID: 31023557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Acrolein Imines to Organic Synthesis, Biofunctional Studies, and Clinical Practice.
    Pradipta AR; Tanaka K
    Chem Rec; 2021 Apr; 21(4):646-662. PubMed ID: 33769681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation.
    Pradipta AR; Ahmadi P; Terashima K; Muguruma K; Fujii M; Ichino T; Maeda S; Tanaka K
    Chem Sci; 2021 Apr; 12(15):5438-5449. PubMed ID: 35340932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
    Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imino [4+4] cycloaddition products as exclusive and biologically relevant acrolein-amine conjugates are intermediates of 3-formyl-3,4-dehydropiperidine (FDP), an acrolein biomarker.
    Takamatsu M; Fukase K; Kurbangalieva A; Tanaka K
    Bioorg Med Chem; 2014 Nov; 22(22):6380-6. PubMed ID: 25438761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice.
    Sekar TV; Foygel K; Ilovich O; Paulmurugan R
    Theranostics; 2014; 4(5):460-74. PubMed ID: 24669276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme/abzyme prodrug activation systems: potential use in clinical oncology.
    Nishi Y
    Curr Pharm Des; 2003; 9(26):2113-30. PubMed ID: 14529409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.
    Dong Y; Tu Y; Wang K; Xu C; Yuan Y; Wang J
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7168-7172. PubMed ID: 32003112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,6,9-Triazabicyclo[3.3.1]nonanes as overlooked amino-modification products by acrolein.
    Tsutsui A; Tanaka K
    Org Biomol Chem; 2013 Nov; 11(41):7208-11. PubMed ID: 24057436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Evaluation of Bioorthogonal Decaging with trans-Cyclooctene: The Effect of Fluorine Substituents on Aryl Azide Reactivity and Decaging from the 1,2,3-Triazoline.
    Matikonda SS; Fairhall JM; Fiedler F; Sanhajariya S; Tucker RAJ; Hook S; Garden AL; Gamble AB
    Bioconjug Chem; 2018 Feb; 29(2):324-334. PubMed ID: 29327914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing luminescent ruthenium prodrug for precise cancer therapy and rapid clinical diagnosis.
    Zhao Z; Zhang X; Li CE; Chen T
    Biomaterials; 2019 Feb; 192():579-589. PubMed ID: 30551086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment.
    Maslah H; Skarbek C; Pethe S; Labruère R
    Eur J Med Chem; 2020 Dec; 207():112670. PubMed ID: 32858470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug applications for targeted cancer therapy.
    Giang I; Boland EL; Poon GM
    AAPS J; 2014 Sep; 16(5):899-913. PubMed ID: 25004822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro reactivity of the antineoplastic drug carmustin and acrolein with model peptides.
    Carbone V; Salzano A; Pucci P; Fiume I; Pocsfalvi G; Sannolo N; Di Landa G; Malorni A
    J Pept Res; 1997 Jun; 49(6):586-95. PubMed ID: 9266487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?
    Nawa A; Tanino T; Luo C; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Nishiyama Y; Kikkawa F
    Anticancer Agents Med Chem; 2008 Feb; 8(2):232-9. PubMed ID: 18288924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
    Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
    J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT.
    Tietze LF; Schmuck K
    Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.